Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.1 USD | -0.86% | -9.32% | +338.96% |
May. 08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
May. 08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 55.24 | 64.78 | 64.78 |
Spread/Res. | -14.74% | -27.29% | -27.29% |
Spread/Supp. | +8.93% | +112.07% | +155.56% |
Support | 43.24 | 22.21 | 18.43 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- JANX Stock
- Charts Janux Therapeutics, Inc.